 | • レポートコード：QFJ1-5740 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、女性性機能障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・女性性機能障害治療の市場動向 ・企業の競争状況、市場シェア ・女性性機能障害治療の種類別市場規模と予測2016-2027（非ホルモン療法、ホルモン療法） ・女性性機能障害治療の用途別市場規模と予測2016-2027（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他） ・女性性機能障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・女性性機能障害治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性性機能障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性性機能障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性性機能障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AMAG Pharmaceuticals Inc.、Duchesnay Inc.、Emotional Brain BV、Novo Nordisk AS、Sprout Pharmaceuticals Inc.） ・結論 |
Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in women will increase the incidence of female sexual dysfunctions. This will provide considerable growth opportunities to market participants.
Mental health conditions such as depression are being recognized as critical health issues mostly among women. As a result, many pharmaceutical companies are releasing drugs and therapies to treat these conditions leading to an increase in the consumption of antidepressants, antipsychotics, and antiepileptics. Moreover, there is also an increase in the consumption of contraceptives. These drugs cause sexual dysfunctions in women.
Market Analysis and Insights: Global Female Sexual Dysfunction Treatment Market
The global Female Sexual Dysfunction Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Sexual Dysfunction Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Sexual Dysfunction Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Female Sexual Dysfunction Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Female Sexual Dysfunction Treatment market.
Global Female Sexual Dysfunction Treatment Scope and Market Size
Female Sexual Dysfunction Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Sexual Dysfunction Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-hormonal Therapy
Hormonal Therapy
Segment by Application
Sexual Desire Disorders
Sexual Arousal Disorders
Orgasm Disorders
Sexual Pain Disorders
Post-orgasmic Diseases
Pelvic Floor Dysfunction
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AMAG Pharmaceuticals Inc.
Duchesnay Inc.
Emotional Brain BV
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-hormonal Therapy
1.2.3 Hormonal Therapy
1.3 Market by Application
1.3.1 Global Female Sexual Dysfunction Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sexual Desire Disorders
1.3.3 Sexual Arousal Disorders
1.3.4 Orgasm Disorders
1.3.5 Sexual Pain Disorders
1.3.6 Post-orgasmic Diseases
1.3.7 Pelvic Floor Dysfunction
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Female Sexual Dysfunction Treatment Market Perspective (2016-2027)
2.2 Female Sexual Dysfunction Treatment Growth Trends by Regions
2.2.1 Female Sexual Dysfunction Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Female Sexual Dysfunction Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Female Sexual Dysfunction Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Female Sexual Dysfunction Treatment Industry Dynamic
2.3.1 Female Sexual Dysfunction Treatment Market Trends
2.3.2 Female Sexual Dysfunction Treatment Market Drivers
2.3.3 Female Sexual Dysfunction Treatment Market Challenges
2.3.4 Female Sexual Dysfunction Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Female Sexual Dysfunction Treatment Players by Revenue
3.1.1 Global Top Female Sexual Dysfunction Treatment Players by Revenue (2016-2021)
3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Female Sexual Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Female Sexual Dysfunction Treatment Revenue
3.4 Global Female Sexual Dysfunction Treatment Market Concentration Ratio
3.4.1 Global Female Sexual Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Sexual Dysfunction Treatment Revenue in 2020
3.5 Female Sexual Dysfunction Treatment Key Players Head office and Area Served
3.6 Key Players Female Sexual Dysfunction Treatment Product Solution and Service
3.7 Date of Enter into Female Sexual Dysfunction Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Female Sexual Dysfunction Treatment Breakdown Data by Type
4.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Type (2016-2021)
4.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2022-2027)
5 Female Sexual Dysfunction Treatment Breakdown Data by Application
5.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Application (2016-2021)
5.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Female Sexual Dysfunction Treatment Market Size (2016-2027)
6.2 North America Female Sexual Dysfunction Treatment Market Size by Type
6.2.1 North America Female Sexual Dysfunction Treatment Market Size by Type (2016-2021)
6.2.2 North America Female Sexual Dysfunction Treatment Market Size by Type (2022-2027)
6.2.3 North America Female Sexual Dysfunction Treatment Market Size by Type (2016-2027)
6.3 North America Female Sexual Dysfunction Treatment Market Size by Application
6.3.1 North America Female Sexual Dysfunction Treatment Market Size by Application (2016-2021)
6.3.2 North America Female Sexual Dysfunction Treatment Market Size by Application (2022-2027)
6.3.3 North America Female Sexual Dysfunction Treatment Market Size by Application (2016-2027)
6.4 North America Female Sexual Dysfunction Treatment Market Size by Country
6.4.1 North America Female Sexual Dysfunction Treatment Market Size by Country (2016-2021)
6.4.2 North America Female Sexual Dysfunction Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Female Sexual Dysfunction Treatment Market Size (2016-2027)
7.2 Europe Female Sexual Dysfunction Treatment Market Size by Type
7.2.1 Europe Female Sexual Dysfunction Treatment Market Size by Type (2016-2021)
7.2.2 Europe Female Sexual Dysfunction Treatment Market Size by Type (2022-2027)
7.2.3 Europe Female Sexual Dysfunction Treatment Market Size by Type (2016-2027)
7.3 Europe Female Sexual Dysfunction Treatment Market Size by Application
7.3.1 Europe Female Sexual Dysfunction Treatment Market Size by Application (2016-2021)
7.3.2 Europe Female Sexual Dysfunction Treatment Market Size by Application (2022-2027)
7.3.3 Europe Female Sexual Dysfunction Treatment Market Size by Application (2016-2027)
7.4 Europe Female Sexual Dysfunction Treatment Market Size by Country
7.4.1 Europe Female Sexual Dysfunction Treatment Market Size by Country (2016-2021)
7.4.2 Europe Female Sexual Dysfunction Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size (2016-2027)
8.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Type
8.2.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Application
8.3.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region
8.4.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Female Sexual Dysfunction Treatment Market Size (2016-2027)
9.2 Latin America Female Sexual Dysfunction Treatment Market Size by Type
9.2.1 Latin America Female Sexual Dysfunction Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Female Sexual Dysfunction Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Female Sexual Dysfunction Treatment Market Size by Type (2016-2027)
9.3 Latin America Female Sexual Dysfunction Treatment Market Size by Application
9.3.1 Latin America Female Sexual Dysfunction Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Female Sexual Dysfunction Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Female Sexual Dysfunction Treatment Market Size by Application (2016-2027)
9.4 Latin America Female Sexual Dysfunction Treatment Market Size by Country
9.4.1 Latin America Female Sexual Dysfunction Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Female Sexual Dysfunction Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size (2016-2027)
10.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type
10.2.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application
10.3.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country
10.4.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals Inc.
11.1.1 AMAG Pharmaceuticals Inc. Company Details
11.1.2 AMAG Pharmaceuticals Inc. Business Overview
11.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Introduction
11.1.4 AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2016-2021)
11.1.5 AMAG Pharmaceuticals Inc. Recent Development
11.2 Duchesnay Inc.
11.2.1 Duchesnay Inc. Company Details
11.2.2 Duchesnay Inc. Business Overview
11.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Introduction
11.2.4 Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2016-2021)
11.2.5 Duchesnay Inc. Recent Development
11.3 Emotional Brain BV
11.3.1 Emotional Brain BV Company Details
11.3.2 Emotional Brain BV Business Overview
11.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Introduction
11.3.4 Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2016-2021)
11.3.5 Emotional Brain BV Recent Development
11.4 Novo Nordisk AS
11.4.1 Novo Nordisk AS Company Details
11.4.2 Novo Nordisk AS Business Overview
11.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Introduction
11.4.4 Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2016-2021)
11.4.5 Novo Nordisk AS Recent Development
11.5 Sprout Pharmaceuticals Inc.
11.5.1 Sprout Pharmaceuticals Inc. Company Details
11.5.2 Sprout Pharmaceuticals Inc. Business Overview
11.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Introduction
11.5.4 Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2016-2021)
11.5.5 Sprout Pharmaceuticals Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-hormonal Therapy
Table 3. Key Players of Hormonal Therapy
Table 4. Global Female Sexual Dysfunction Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Female Sexual Dysfunction Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Female Sexual Dysfunction Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Female Sexual Dysfunction Treatment Market Share by Regions (2016-2021)
Table 8. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Female Sexual Dysfunction Treatment Market Share by Regions (2022-2027)
Table 10. Female Sexual Dysfunction Treatment Market Trends
Table 11. Female Sexual Dysfunction Treatment Market Drivers
Table 12. Female Sexual Dysfunction Treatment Market Challenges
Table 13. Female Sexual Dysfunction Treatment Market Restraints
Table 14. Global Female Sexual Dysfunction Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Female Sexual Dysfunction Treatment Market Share by Players (2016-2021)
Table 16. Global Top Female Sexual Dysfunction Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Sexual Dysfunction Treatment as of 2020)
Table 17. Ranking of Global Top Female Sexual Dysfunction Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Female Sexual Dysfunction Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Female Sexual Dysfunction Treatment Product Solution and Service
Table 21. Date of Enter into Female Sexual Dysfunction Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Female Sexual Dysfunction Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Female Sexual Dysfunction Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Female Sexual Dysfunction Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Female Sexual Dysfunction Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Female Sexual Dysfunction Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Female Sexual Dysfunction Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Female Sexual Dysfunction Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Female Sexual Dysfunction Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Female Sexual Dysfunction Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Female Sexual Dysfunction Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Female Sexual Dysfunction Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Female Sexual Dysfunction Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Female Sexual Dysfunction Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Female Sexual Dysfunction Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Female Sexual Dysfunction Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Female Sexual Dysfunction Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Female Sexual Dysfunction Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Female Sexual Dysfunction Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Female Sexual Dysfunction Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Female Sexual Dysfunction Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AMAG Pharmaceuticals Inc. Company Details
Table 62. AMAG Pharmaceuticals Inc. Business Overview
Table 63. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product
Table 64. AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2016-2021) & (US$ Million)
Table 65. AMAG Pharmaceuticals Inc. Recent Development
Table 66. Duchesnay Inc. Company Details
Table 67. Duchesnay Inc. Business Overview
Table 68. Duchesnay Inc. Female Sexual Dysfunction Treatment Product
Table 69. Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2016-2021) & (US$ Million)
Table 70. Duchesnay Inc. Recent Development
Table 71. Emotional Brain BV Company Details
Table 72. Emotional Brain BV Business Overview
Table 73. Emotional Brain BV Female Sexual Dysfunction Treatment Product
Table 74. Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2016-2021) & (US$ Million)
Table 75. Emotional Brain BV Recent Development
Table 76. Novo Nordisk AS Company Details
Table 77. Novo Nordisk AS Business Overview
Table 78. Novo Nordisk AS Female Sexual Dysfunction Treatment Product
Table 79. Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2016-2021) & (US$ Million)
Table 80. Novo Nordisk AS Recent Development
Table 81. Sprout Pharmaceuticals Inc. Company Details
Table 82. Sprout Pharmaceuticals Inc. Business Overview
Table 83. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product
Table 84. Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2016-2021) & (US$ Million)
Table 85. Sprout Pharmaceuticals Inc. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Sexual Dysfunction Treatment Market Share by Type: 2020 VS 2027
Figure 2. Non-hormonal Therapy Features
Figure 3. Hormonal Therapy Features
Figure 4. Global Female Sexual Dysfunction Treatment Market Share by Application: 2020 VS 2027
Figure 5. Sexual Desire Disorders Case Studies
Figure 6. Sexual Arousal Disorders Case Studies
Figure 7. Orgasm Disorders Case Studies
Figure 8. Sexual Pain Disorders Case Studies
Figure 9. Post-orgasmic Diseases Case Studies
Figure 10. Pelvic Floor Dysfunction Case Studies
Figure 11. Other Case Studies
Figure 12. Female Sexual Dysfunction Treatment Report Years Considered
Figure 13. Global Female Sexual Dysfunction Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Female Sexual Dysfunction Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Female Sexual Dysfunction Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Female Sexual Dysfunction Treatment Market Share by Regions (2022-2027)
Figure 17. Global Female Sexual Dysfunction Treatment Market Share by Players in 2020
Figure 18. Global Top Female Sexual Dysfunction Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Sexual Dysfunction Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Female Sexual Dysfunction Treatment Revenue in 2020
Figure 20. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Female Sexual Dysfunction Treatment Market Share by Type (2016-2027)
Figure 24. North America Female Sexual Dysfunction Treatment Market Share by Application (2016-2027)
Figure 25. North America Female Sexual Dysfunction Treatment Market Share by Country (2016-2027)
Figure 26. United States Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Female Sexual Dysfunction Treatment Market Share by Type (2016-2027)
Figure 30. Europe Female Sexual Dysfunction Treatment Market Share by Application (2016-2027)
Figure 31. Europe Female Sexual Dysfunction Treatment Market Share by Country (2016-2027)
Figure 32. Germany Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Region (2016-2027)
Figure 42. China Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Female Sexual Dysfunction Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Female Sexual Dysfunction Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Female Sexual Dysfunction Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Female Sexual Dysfunction Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AMAG Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2016-2021)
Figure 62. Duchesnay Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2016-2021)
Figure 63. Emotional Brain BV Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2016-2021)
Figure 64. Novo Nordisk AS Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2016-2021)
Figure 65. Sprout Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…- 女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
- 女性用性的欲求低下障害治療のグローバル市場調査 2019年 The global Female Hypoactive Sexual Desire Disorder Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Female Hypoactive Sexual Desire Disorder Therapeutics volume and value at global leve…
- 世界のミトコンドリア病治療市場規模・現状・予測（2021年-2027年） Mitochondrial disorders are inherited chronic disorders characterized by a wide range of biochemical and genetic mitochondrial defects and mutations. The disorder affects multiple organs, which includes brain, heart, liver, skeletal muscles, kidney, and respiratory systems. Market Analysis and Insig…
- 世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Frontotemporal Disorders Treatment Market The global Frontotemporal Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …